409 related articles for article (PubMed ID: 35131514)
1. Evaluation of Combination Therapy With Etanercept and Systemic Corticosteroids for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Observational Study.
Zhang J; Lu CW; Chen CB; Wang CW; Chen WT; Cheng B; Ji C; Chung WH
J Allergy Clin Immunol Pract; 2022 May; 10(5):1295-1304.e6. PubMed ID: 35131514
[TBL] [Abstract][Full Text] [Related]
2. Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.
Jacobsen A; Olabi B; Langley A; Beecker J; Mutter E; Shelley A; Worley B; Ramsay T; Saavedra A; Parker R; Stewart F; Pardo Pardo J
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013130. PubMed ID: 35274741
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
4. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
Chen J; Wang B; Zeng Y; Xu H
Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352
[TBL] [Abstract][Full Text] [Related]
5. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
[TBL] [Abstract][Full Text] [Related]
6. Etanercept treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Tian CC; Ai XC; Ma JC; Hu FQ; Liu XT; Luo YJ; Tan GZ; Zhang JM; Li XQ; Guo Q; Zeng FQ; Shi ZR; Wang L
Ann Allergy Asthma Immunol; 2022 Sep; 129(3):360-365.e1. PubMed ID: 35598882
[TBL] [Abstract][Full Text] [Related]
7. Intravenous Immunoglobulin Combined With Corticosteroids for the Treatment of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Propensity-Matched Retrospective Study in China.
Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
Front Pharmacol; 2021; 12():750173. PubMed ID: 35115922
[No Abstract] [Full Text] [Related]
8. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.
Schneider JA; Cohen PR
Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Aihara M; Kano Y; Fujita H; Kambara T; Matsukura S; Katayama I; Azukizawa H; Miyachi Y; Endo Y; Asada H; Miyagawa F; Morita E; Kaneko S; Abe R; Ochiai T; Sueki H; Watanabe H; Nagao K; Aoyama Y; Sayama K; Hashimoto K; Shiohara T;
J Dermatol; 2015 Aug; 42(8):768-77. PubMed ID: 25982480
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Plasmapheresis vs Immunoglobulin as First Treatment After Ineffective Systemic Corticosteroid Therapy for Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Miyamoto Y; Ohbe H; Kumazawa R; Matsui H; Fushimi K; Yasunaga H; Ohta B
JAMA Dermatol; 2023 May; 159(5):481-487. PubMed ID: 36884227
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy: Etanercept and intravenous immunoglobulin for the acute treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.
Pham CH; Gillenwater TJ; Nagengast E; McCullough MC; Peng DH; Garner WL
Burns; 2019 Nov; 45(7):1634-1638. PubMed ID: 31466921
[TBL] [Abstract][Full Text] [Related]
12. Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.
Wang CW; Yang LY; Chen CB; Ho HC; Hung SI; Yang CH; Chang CJ; Su SC; Hui RC; Chin SW; Huang LF; Lin YY; Chang WY; Fan WL; Yang CY; Ho JC; Chang YC; Lu CW; Chung WH;
J Clin Invest; 2018 Mar; 128(3):985-996. PubMed ID: 29400697
[TBL] [Abstract][Full Text] [Related]
13. Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy.
Lin M; Gong T; Ruan S; Lv X; Chen R; Su X; Cheng B; Ji C
J Inflamm Res; 2024; 17():2337-2351. PubMed ID: 38645875
[TBL] [Abstract][Full Text] [Related]
14. Toxic Epidermal Necrolysis: A Review of Past and Present Therapeutic Approaches.
Singh N; Phillips M
Skin Therapy Lett; 2022 Sep; 27(5):7-13. PubMed ID: 36469487
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Intravenous Immunoglobulin Combined with Corticosteroid on the Progression of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Meta-Analysis.
Ye LP; Zhang C; Zhu QX
PLoS One; 2016; 11(11):e0167120. PubMed ID: 27902746
[TBL] [Abstract][Full Text] [Related]
16. Toxic epidermal necrolysis: performance of SCORTEN and the score-based comparison of the efficacy of corticosteroid therapy and intravenous immunoglobulin combined therapy in China.
Zhu QY; Ma L; Luo XQ; Huang HY
J Burn Care Res; 2012; 33(6):e295-308. PubMed ID: 22955159
[TBL] [Abstract][Full Text] [Related]
17. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
[TBL] [Abstract][Full Text] [Related]
18. A Bayesian Network Meta-Analysis of the Effect of Targeted Therapies on the Total Length of Hospital Stay in Children with Drug-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Syndrome.
Ozerturk S; Derici Yildirim D; Arikoglu T; Kuyucu S; Kont Ozhan A
Pediatr Allergy Immunol Pulmonol; 2024 Mar; 37(1):22-32. PubMed ID: 38484271
[No Abstract] [Full Text] [Related]
19. A 10-year retrospective cohort study of the management of toxic epidermal necrolysis and Stevens-Johnson syndrome in a New South Wales state referral hospital from 2006 to 2016.
Chan L; Cook DK
Int J Dermatol; 2019 Oct; 58(10):1141-1147. PubMed ID: 30908601
[TBL] [Abstract][Full Text] [Related]
20. The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre.
Lee HY; Lim YL; Thirumoorthy T; Pang SM
Br J Dermatol; 2013 Dec; 169(6):1304-9. PubMed ID: 24007192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
